Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Esmerone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,154Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lupin Gets Tentative FDA Nod For Sugammadex Injection
    Lupin Gets Tentative FDA Nod For Sugammadex Injection

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lupin-receives-tentative-approval-from-us-fda-for-sugammadex-injection-302730068.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Aspiro’s Generics Rocuronium Bromide Receives Approval in US
    Aspiro’s Generics Rocuronium Bromide Receives Approval in US

    04 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220124

    FDA
    04 Mar 2026
    Share Share
    Knack’s Generics Rocuronium Bromide Receives Approval in US
    Knack’s Generics Rocuronium Bromide Receives Approval in US

    06 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213476

    FDA
    06 Jan 2026
    Share Share
    Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection
    Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection

    18 Dec 2025

    // PRESS RELEASE

    https://www.fresenius-kabi.com/us/news-and-events/first-ever-rocuronium-bromide-injection-stable-at-room-temperatu

    PRESS RELEASE
    18 Dec 2025
    Share Share
    Fresenius Kabi Launches Room-Temperature Stable Rocuronium
    Fresenius Kabi Launches Room-Temperature Stable Rocuronium

    18 Dec 2025

    // PRESS RELEASE

    https://www.fresenius-kabi.com/us/news-and-events/first-ever-rocuronium-bromide-injection-stable-at-room-temperatu

    PRESS RELEASE
    18 Dec 2025
    Share Share
    Sterinova’s Rocuronium Bromide Receives Approval in US
    Sterinova’s Rocuronium Bromide Receives Approval in US

    24 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219108

    FDA
    24 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.